Standout Papers

<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signal... 2007 2026 2013 2019 3.5k
  1. MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling (2007)
    Jeffrey A. Engelman, Kreshnik Zejnullahu et al. Science

Immediate Impact

9 by Nobel laureates 19 from Science/Nature 125 standout
Sub-graph 1 of 15

Citing Papers

Lung cancer
2021 Standout
Designed protein logic to target cells with precise combinations of surface antigens
2020 StandoutScienceNobel
1 intermediate paper

Works of Alison J. Holmes being referenced

MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
2007 StandoutScience

Author Peers

Author Last Decade Papers Cites
Alison J. Holmes 3458 3089 495 2288 16 5.3k
Youngchul Song 2639 2984 571 2959 18 5.4k
F. Michael Yakes 1088 2256 515 3406 20 5.8k
Andrew M. Rogers 2666 2578 559 2415 21 4.6k
Jeremy Stinson 1422 1930 492 3013 22 5.1k
J. Guillermo Paez 5372 4680 532 3530 9 8.5k
Jeffrey C. Lee 5694 5036 523 4108 14 9.3k
Samuel E. DePrimo 2423 2164 490 2716 39 5.2k
Paula Herman 5435 4669 577 3417 13 8.2k
Igor Vivanco 1334 1915 768 4930 28 6.9k
Kreshnik Zejnullahu 3161 3115 541 3071 16 5.4k

All Works

Loading papers...

Rankless by CCL
2026